![]() |
News Alert
|
Care Decision Corp. (OTCBB: CDED) |
6 Month Target Price: $.22 |
|
| Shares Outstanding |
70.0 million |
|
|
|
| Approx. Float |
15 million |
|
|
|
| 6 Month Price Proj. |
$.22 |
|
|
|
|
A Few Reasons to Own CDED:
| 1. |
Enormous underdeveloped market potential. Medical IT markets expected to grow to $20 billion in 2004 and $100 billion by the close of 2006. |
| 2. |
Few competitors in market with no established leader. Opportunity for "first to market" designation and resultant market share benefit. |
| 3. |
Multiple Patents are currently anticipating short-term approval distinguishing technology and protecting it from competitive duplication. |
| 4. |
CDED signs deal to acquire Netcare Health Group Subsidiary, CDED Gains Expected $5 Million Annual Revenue Stream and Base of 800 Physicians for Deployment of E-Health Products. |
| 5. |
CDED estimates revenue of $6.4 Million for 2003, and $15.7 Million for 2004. |
| 6. |
Deeply experienced management team with demonstrated success in the healthcare products and information technology industries. |
| 7. |
Potential acquisition target. There is a strong possibility that CDED could become a "technology acquisition target" stock for a health insurer or pharmaceutical company. |
| 8. |
CDED is currently grossly undervalued providing potential opportunity for rapid investment return and appreciation. |
|
| UPDATE |
|
Great News! It is always nice to see Micro Cap Company's making smart deals. Read the press release below, and you will notice how CDED gets a double bang out of this deal. First, this transaction gives CDED entry into the Worker's Compensation segment of the Healthcare market, and secondly, this deal brings Million's to CDED balance sheet.
The best part of this press release is quoted by the CEO "This acquisition has also yielded the by-product of a financial bonanza that has tripled the size of the Company's asset base to $3.5 million. We anticipate that this appreciation, and other actions contemplated, will precipitate CareDecision's filing of an application for listing to the AMEX stock exchange."
Hopefully in the near future CDED will deliver to us even greater PR. Good Luck
|
| Press Release |
|
CAREDECISION CORP. ACQUIRES INNOVATIVE WEB TECHNOLOGIES FROM INVESTMENT CONTENT CORP.
-- -- -- -- --
TECHNOLOGY ACQUISITION TRIPLES ASSET BASE TO $3.5 MILLION, POSITIONS COMPANY FOR AMEX EXCHANGE
New Yok, NY - January 28, 2003 -- CareDecision Corp. (OTCBB:CDED), the e-health technology developer and medical PDA innovator, today announced that it has acquired title to specific intellectual properties and technologies from Investment Content Corp., a recognized content software and middleware developer. The acquisition immediately opens a strategic and technological portal for CareDecision Corp. into the Worker's Compensation claims and case intervention healthcare segment. CareDecision intends to shortly file trademarks on the integrated technology under the brand MD@WorkTM.
The acquired financial management technology contributes to the Company's product portfolio a real-time portal for PDA-based work-injury claim management, claim review and case intervention services. MD@WorkTM when integrated with the Company's current products and technologies will yield the most advanced and comprehensive system of technological tools and assets available to assist physicians with informed clinical decision making, therapy construction, administrative recording and filing, and accelerated adjudication and payment.
Robert Cox, CareDecision CEO stated, "Our central governing principle requires us to continually advance our products and systems through the development and addition of components which simplistically and inexpensively provide solutions to the problems facing the nation's practicing physicians. MD@WorkTM satisfies that fundamental requirement by furnishing current and prospective clients with the mechanism to electronically record and file work-injury claims and the capability of accelerating the intervention and adjudication process. No competitive system can even remotely approach the depth of asset rich features or the breath of problem solving remedies that are now available under the CareDecison product umbrella. "
Mr. Cox continued, "This acquisition has also yielded the by-product of a financial bonanza that has tripled the size of the Company's asset base to $3.5 million. We anticipate that this appreciation, and other actions contemplated, will precipitate CareDecision's filing of an application for listing to the AMEX stock exchange. The acquisition has therefore resulted in the expansion of our product's functionality, the dimension of our market application and the value of our shareholders' investment.
About CareDecision Corp.
CareDecision Corp. is an e-health PDA-based information technology company that provides physicians with sophisticated medical information solutions at the point-of-care. The company's patent-pending software systems, communication technologies and clinical applications furnish office-based physicians, EMR physicians, and industrial medicine practitioners with vital patient information using an e-health business model, on a Microsoft Windows CE-based PDA
Forward-Looking Statements
This news release contains forward-looking statements about our business or financial condition and prospects that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as "believes," "expects," "intends," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions. All forward-looking statements are intended to be covered by the safe harbor created by Section 21E of the Securities Exchange Act of 1934.
|
| Valuation |
|
In the $1.6 trillion healthcare field, CDED has a market capitalization of only $3 Million Dollars. CDED is now moving into the deployment phase of MD@Hand and the implementation phase of its marketing program. With the planned acquisition of Netcare Health Group, and several agreements already in place, including Pharmacare Corporation, a subsidiary of (NYSE:CVS), CDED is projecting revenues of about $6.4 Million this year and $15.7 Million next year, and also to be profitable.
Since CDED is a development stage company, which is moving from R&D to revenues and profits (particularly this year and beyond), in our opinion, the best way to value CDED is on this year’s anticipated revenues and earnings potential.
According to Multex, CDED’s peer group trades in the marketplace at 7.3 times trailing twelve months revenue.
In our opinion, since CDED is the new kid on the block, and trying to make a name for itself, if over the next six months CDED were to trade in the marketplace at 1/3 the multiple of its peers, then based on projected revenues of $6.4 Million Dollars this year, with about 70 million shares outstanding, this would equate to a 6 month target price of $0.22.
|
| Conclusion |
Like many exciting opportunities that we uncover, CDED is a development stage company that may be poised to move to the next level. Once the rollout of CDED's products and services begins in earnest we believe that good things could happen including a higher market capitalization and potential rapid stock price appreciation, as the investing public becomes more aware of CDED potential. |
|
******* Important Notice and Disclaimer: Please Read *******
Investor Insights, and affiliates (II), publishes reports providing information on selected companies that II believes has investment potential. II is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. II accepts no liability for any loss arising from an investor's reliance on or use of this report. An investment in CDED is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. An affiliate of II has been hired by the company, and additionally received 2.5 million free trading shares of common stock of CDED by a third party for the publication and circulation of this report. II intends to sell all or a portion of the of the CDED stock at or about the time of publication of this report. Subsequently II may buy or sell shares of CDED stock in the open market. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. For further details concerning these risks and uncertainties, see the SEC filings of CDED including the company's most recent annual and quarterly reports.
|
|
